Endoxifen dual benefits, alleviating symptoms of bipolar disorder, and a potential novel anticraving agent for alcohol dependence: A case series
Odisha Journal of Psychiatry · 2024
DOI: 10.4103/ojp.ojp_19_24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Odisha Journal of Psychiatry, 2024. Verfasst von Soumya Ranjan Dash und 2 weiteren Autor:innen. Die Arbeit nennt 7 Literaturangaben.
Abstract (Originalsprache)
Substance use may be a risk factor and precipitator in episodes of bipolar affective disorder (BPAD). BPAD increases vulnerability to substance use as a part of increased risk behavior and/or self-medication, ultimately leading to dependence. Endoxifen is an active metabolite of tamoxifen with a four-fold protein kinase C inhibitory activity. The efficacy of endoxifen is shown in reducing manic symptoms faster and has a safe adverse effect profile. [1] This case series explores the effectiveness of endoxifen in reducing both manic symptoms and alcohol cravings in patients with mania and comorbid alcohol dependence. The severity of mania was monitored using the Young Mania Rating Scale, while alcohol cravings were evaluated using the Alcohol Use Disorders Identification Test (AUDIT) [2] scores before and after the intervention. All three patients showed a significant reduction in manic symptoms following endoxifen treatment. In addition, there was a significant decrease in AUDIT scores, indicating a reduction in alcohol cravings. These findings suggest that endoxifen may have dual benefits in managing mania and may be a potential anticraving agent.
Zitieren
APA
Dash, S. R., Dixit, K., & Sahoo, S. (2024). Endoxifen dual benefits, alleviating symptoms of bipolar disorder, and a potential novel anticraving agent for alcohol dependence: A case series. Odisha Journal of Psychiatry. https://doi.org/10.4103/ojp.ojp_19_24
Vancouver
Dash SR, Dixit K, Sahoo S. Endoxifen dual benefits, alleviating symptoms of bipolar disorder, and a potential novel anticraving agent for alcohol dependence: A case series. Odisha Journal of Psychiatry. 2024. doi:10.4103/ojp.ojp_19_24
BibTeX
@article{Dash2024,
author = {Dash, Soumya Ranjan and Dixit, Kopal and Sahoo, Surjeet},
title = {Endoxifen dual benefits, alleviating symptoms of bipolar disorder, and a potential novel anticraving agent for alcohol dependence: A case series},
journal = {Odisha Journal of Psychiatry},
year = {2024},
doi = {10.4103/ojp.ojp_19_24}
}
EUVIMED